Urothelial Carcinoma Bladder
Oncology·MeSH: Non-Muscle Invasive Bladder Neoplasms
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
2 drugs in development·1 company·9 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Urothelial Carcinoma Bladder?
BioSniper tracks 2 drugs in development for Urothelial Carcinoma Bladder across 1 company.
How many clinical trials target Urothelial Carcinoma Bladder?
There are 9 clinical trials targeting Urothelial Carcinoma Bladder tracked by BioSniper.
What is the prevalence of Urothelial Carcinoma Bladder?
The estimated prevalence of Urothelial Carcinoma Bladder is approximately 61.0 per 100,000 population.
Deep-dive into Urothelial Carcinoma Bladder
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis